These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33453224)

  • 1. β-lactam antibiotics to tame down molecular pathways of Alzheimer's disease.
    Kumari S; Deshmukh R
    Eur J Pharmacol; 2021 Mar; 895():173877. PubMed ID: 33453224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of natural products for the treatment of Alzheimer's disease.
    Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
    Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.
    Siddiqui A; Shah Z; Jahan RN; Othman I; Kumari Y
    Biomed Pharmacother; 2021 Dec; 144():112250. PubMed ID: 34607104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review).
    Cai Z
    Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.
    Forest KH; Nichols RA
    Trends Mol Med; 2019 Aug; 25(8):685-695. PubMed ID: 31248781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks.
    Tajbakhsh A; Read M; Barreto GE; Ávila-Rodriguez M; Gheibi-Hayat SM; Sahebkar A
    Eur J Pharmacol; 2021 Mar; 895():173873. PubMed ID: 33460611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
    Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P
    ACS Chem Neurosci; 2017 Jul; 8(7):1435-1437. PubMed ID: 28586203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
    Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
    Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's Disease Therapeutic Approaches.
    Revi M
    Adv Exp Med Biol; 2020; 1195():105-116. PubMed ID: 32468465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surprise neuroprotective potential of beta-lactam antibiotics.
    Senior K
    Drug Discov Today; 2005 Mar; 10(5):300. PubMed ID: 15749274
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review.
    Vincent B
    Pharmacol Res; 2018 Aug; 134():223-237. PubMed ID: 29981776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlocking the concealed targets using system biology mapping for Alzheimer's disease.
    Joshi P; Kawade V; Dhulap S; Goel M
    Pharmacol Rep; 2019 Dec; 71(6):1104-1107. PubMed ID: 31634797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.